FDA Enforcement Class II Terminated

Randox Laboratories Ltd. Catalogue Number CQ5052, Lot Number 4244CK (relabeled as Response Biomedical Catalogue Number C2003-2, Lot #070318) IFU: "RAMP Cardiac Controls *** CAT. No.: C2003-2 *** Size: 3 x 3 ML". Product Usage: use in the quality control of cardiac marker assays run on the RAMP¿ platform.

Recall: Z-1461-2020 · Reported March 18, 2020

Enforcement

Recall Number
Z-1461-2020
Event ID
84514
Classification
Class II
Status
Terminated
Product Type
Devices
Firm
Response Biomedical Corp.
Voluntary / Mandated
Voluntary: Firm initiated
Initial Notification
Letter
Report Date
March 18, 2020
Initiation Date
March 15, 2019
Classification Date
March 10, 2020
Termination Date
June 9, 2022
Address
1781 75th Ave W, Vancouver, N/A, Canada

Description

Randox Laboratories Ltd. Catalogue Number CQ5052, Lot Number 4244CK (relabeled as Response Biomedical Catalogue Number C2003-2, Lot #070318) IFU: "RAMP Cardiac Controls *** CAT. No.: C2003-2 *** Size: 3 x 3 ML". Product Usage: use in the quality control of cardiac marker assays run on the RAMP¿ platform.

Reason

The form received three complaints related to the user obtaining a result that fell below the target range for CK-MB provided in the RAMP Cardiac Controls Instructions for Use. Via in-house monitoring, determined that liquid Cardiac Control has seen a decrease in CK-MB Levels of up to 57% signal loss within 11 months. Shelf-life of product is 24 months.

Code Info

Randox Laboratories Ltd. Catalogue Number CQ5052, Lot Number 4244CK (relabeled as Response Biomedical Catalogue Number C2003-2, Lot #070318). UDI Code: (01) 1 0627966 00508 4 (10) 070318 (17)300919

Distribution

Worldwide distribution: US Nationwide distributions in the states of IN, GA, OK, KS, AZ, SC, NE, NC, MI, FL, CA, MN, and AR. Countries of Canada, Italy, Malaysia, Kuwait, Saudi Arabia, UAE, Ukraine, Russia, Dominican Republic, France, Mexico, Colombia, Singapore, China, Serbia, Romania, and Philippine.

Quantity

543 units